Protein Design Labs Opens Minnesota Manufacturing Facility

Published July 2004

BROOKLYN PARK, MINN. -

Fremont, Calif.-based Protein Design Labs has opened a 210,000-sf commercial-scale biopharmaceutical manufacturing facility in Brooklyn Park , Minn. The facility will produce humanized monoclonal antibodies for the treatment of conditions including cancer and inflammatory diseases.

Copyright 2008 Tradeline Inc.
All Rights Reserved
ISSN: 1096-4894